Unrelated Donor Stem Cell Transplantation
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Myeloproliferative Syndromes
- Acute Lymphoblastic Leukemia
- Acute Myelogenous Leukemia
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Chronic Myelogenous Leukemia
- Hodgkin's Lymphoma
- Large Granulocytic Leukemia
- Multiple Myeloma
- Myelodysplastic Syndromes
- Non Hodgkin's Lymphoma
- Paroxysmal Nocturnal Hemoglobinuria
- Severe Aplastic Anemia
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: Non-RandomizedMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 69 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01364363
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Jeffrey W. Andrey, MD Scripps Clinic Medical Group